Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Rev Invest Clin ; 61(1): 33-40, 2009.
Artigo em Espanhol | MEDLINE | ID: mdl-19507473

RESUMO

INTRODUCTION: Shoulder ultrasonography is revised in the evaluation of complete rotator cuff tears. Also another technique known as artro-ultrasonography, which consist of a 10 mL solution injection inside the articular capsule to observe its escape to the subacromial-subdeltoidea bursae which implicates rotator cuff tear. It is compared against multiple standards like surgery, magnetic resonance, arthrography and rehabilitation to include positive and negative cases. MATERIAL AND METHODS: 181 consecutive cases were studied with ultrasonography, 27 with artro-ultrasonography. The criteria for tear is the absence of the hyper-ecogenicity in the tendon, hypo-ecogenic gaps inside the rotator cuff and distention of the bursae due to the presence of liquid. RESULTS: 69% sensibility and 71% specificity for ultrasonography. 92% sensibility and specificity for artro-ultrasonography. The area under the COR curve is 70% for ultrasonography and 93% for artro-ultrasonography. The artro-ultrasonography modified the diagnosis in nine cases, the majority from normal to tear. Three Radiologists proved the agreement with good results. DISCUSSION: The study contributes to evaluate the performance of ultrasound against multiple standards to correct the great variability in results observed in literature. The contribution of artro-ultrasonography to diagnosis is evaluated. It can be useful in places where accuracy is important and more sophisticated methods like magnetic resonance are not available.


Assuntos
Manguito Rotador/diagnóstico por imagem , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Injeções Intra-Articulares , Cápsula Articular , Imageamento por Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Manguito Rotador/cirurgia , Lesões do Manguito Rotador , Ruptura/diagnóstico por imagem , Ruptura/cirurgia , Sensibilidade e Especificidade , Ultrassonografia , Adulto Jovem
2.
Rev Invest Clin ; 59(3): 197-205, 2007.
Artigo em Espanhol | MEDLINE | ID: mdl-17910412

RESUMO

INTRODUCTION: Rhinosinusitis is one of the more common diseases encountered in outpatient visits to health care. The objective of this study was to determine the most cost-effective antibiotic treatment for patients with acute (RSA) and chronic rhinosinusitis (RSC) that is available at the Mexican Institute of Social Security (IMSS). METHODS: Cost-effectiveness analysis of RSA and RSC treatment from an institutional perspective. Effectiveness outcome was defined as the percentage of cure. A decision tree with a Bayesian approach included the following therapeutic alternatives: ciprofloxacin, gatifloxacin, trimetoprim/sulfametoxazol (TMP/SMX), amoxicilin/clavulanic acid (AAC) and clindamicin. RESULTS: Treatment for RSA with AAC showed a mean cost per cured patient of $ 878 pesos. The remaining antibiotics had a higher cost per unit of success, and therefore the results showed that AAC was the best alternative considering this criterion. The therapy that showed a larger percentage of cured patients in RSC was clindamicin; however, the therapeutic alternative with the lowest cost per successful unit was the one based on ciprofloxacin, which dominates gatifloxacin and AAC. CONCLUSIONS: The most cost-effective alternative in the antibiotic treatment of patients with RSA was ACC while for RSC it was ciprofloxacin; sensitivity analysis showed the strength of the base study results.


Assuntos
Antibacterianos/uso terapêutico , Rinite/tratamento farmacológico , Sinusite/tratamento farmacológico , Doença Aguda , Combinação Amoxicilina e Clavulanato de Potássio/administração & dosagem , Combinação Amoxicilina e Clavulanato de Potássio/uso terapêutico , Antibacterianos/economia , Doença Crônica , Ciprofloxacina/economia , Ciprofloxacina/uso terapêutico , Clindamicina/administração & dosagem , Clindamicina/uso terapêutico , Análise Custo-Benefício , Árvores de Decisões , Custos de Medicamentos , Fluoroquinolonas/administração & dosagem , Fluoroquinolonas/uso terapêutico , Gatifloxacina , Humanos , México/epidemiologia , Rinite/epidemiologia , Sinusite/epidemiologia , Resultado do Tratamento , Combinação Trimetoprima e Sulfametoxazol/administração & dosagem , Combinação Trimetoprima e Sulfametoxazol/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA